AMGN

AMGEN INC

Healthcare • USA

Apr 05 • 04:00PM ET
272.41
0.72 (0.27%)

Company Description

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients wi... read more

State

CA

Name AMGEN INC
Sector Healthcare
Currency USD
FULL TEST - ASSETS 90883000000.0
Market Cap 158147
Company Profile

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients wi... read more
Full Time Employees 26,700
Phone 805 447 1000
Website https://www.amgen.com
CEO Mr. Robert A. Bradway
IPO Date 1983-06-17
Sector Healthcare
Address One Amgen Center Drive, Thousand Oaks, CA 91320-1799